Contact this trialFirst, we need to learn more about you.
Brexpiprazole for Bipolar Disorder
Recruiting2 awardsPhase 3
Montreal, Quebec
This trial is testing whether Brexpiprazole is an effective treatment for bipolar disorder type I depression by improving mood symptoms, cognitive capacity, and global functioning.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service